{'fraction_non_alphanumeric': 0.009596928982725527, 'fraction_numerical': 0.019193857965451054, 'mean_word_length': 5.069767441860465, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
THE UTERINE AND CARDIOVASCULAR EFFECTS OF ORAL FENOTEROL HYDROBROMIDE

Fenoterol hydrobromide was administered as a 5 mg tablet to 10 patients in oxytocin‐induced labour and the effects on uterine activity and on the cardiovascular system of mother and baby were evaluated. The drug took effect within 30 minutes in 8 of the 10 patients and it reduced uterine activity to less than 30 per cent of the original. Fenoterol caused a moderate maternal tachycardia, raised systolic and decreased the diastolic blood pressures.